| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | Chief Research Officer | Common Stock | 82.3K | $11.5M | $139.86 | 07 Oct 2021 | Direct |
| NEUROCRINE BIOSCIENCES INC | Chief Research Officer | Non-Qualified Stock Option | 43.4K | $3.43M | $79.02 | 07 Oct 2021 | Direct |
| NEUROCRINE BIOSCIENCES INC | Chief Research Officer | Restricted Stock Unit | 4.75K | $631K | $132.94 | 31 Jan 2022 | Direct |
| NEUROCRINE BIOSCIENCES INC | Chief Research Officer | Stock Option | 32.3K | 31 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | 31 Jan 2022 | 2 | $0 | 4 | Chief Research Officer | 02 Feb 2022, 19:04 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 07 Oct 2021 | 4 | -$839K | 4 | Chief Research Officer | 12 Oct 2021, 18:32 |